Samuel V. Calzadilla

Author

Also Known As

S Calzadilla, S V Calzadilla, S. V. CALZADILLA, S. V. Calzadilla, Samuel V Calzadilla, Samuel V. CALZADILLA, Samuel V. Calzadilla

Publications

524

Citations

H-Index

Concepts

All Affiliations

Abbott Fund Abbott (United Kingdom)

About

Samuel V. Calzadilla is an author at Abbott Fund specializing in physiology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	187
2	Health Sciences	1	1	97
3	Public Health	1	1	29
4	Anesthesia	1	1	14
5	Biochemistry	1	1	14

Samuel V. Calzadilla

Publications

503

Citations

H-Index

Page 1

	Year	Citations
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist. Terry J. Opgenorth, Andrew Adler, Samuel V. Calzadilla, Journal of Pharmacology and Experimental Therapeutics	1996	209
ABT-627, an endothelin ETA receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain Michael F. Jarvis, Jerry L. Wessale, Chang Zhu, European Journal of Pharmacology Tactile AllodyniaDiabetic Rat ModelHealth SciencesPain MedicineMedicine	2000	97
Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: <i>ex vivo</i> and <i>in vivo</i> studies Jerry L. Wessale, Andrew Adler, Eugene I. Novosad, Clinical Science	2002	61
Azole Endothelin Antagonists. 3. Using Δ log <i>P</i> as a Tool To Improve Absorption Thomas W von Geldern, Daniël J. Hoffman, Jeffrey A. Kester, Journal of Medicinal Chemistry	1996	35
Effects of Endothelin Receptor Antagonists on the Plasma Immunoreactive Endothelin-1 Level Terry J. Opgenorth, Jerry L. Wessale, Douglas B. Dixon, Journal of Cardiovascular Pharmacology InflammationMolecular PharmacologyMedicinePlasma Et-1 LevelPhysiology	2000	31
Spontaneous heart rate, propranolol, and ischaemia-induced ventricular fibrillation in the dog Robert D. Reynolds, Samuel V. Calzadilla, Randall J. Lee Cardiovascular Research Cardiac AnaesthesiaDiastolic FunctionThrombosisPublic HealthCardiology	1978	29
Pharmacology of A-216546: a highly selective antagonist for endothelin ETA receptor Jinshyun R. Wu‐Wong, Douglas B. Dixon, William J. Chiou, European Journal of Pharmacology Molecular PharmacologyEndothelin Eta ReceptorMedicinePhysiologyPharmacology	1999	16
(–)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a Novel ATP-Sensitive Potassium Channel Opener: Hemodynamic Comparison to ZD-6169, WAY-133537, and Nifedipine in the Anesthetized Canine Ryan M. Fryer, Lee C. Preusser, Samuel V. Calzadilla, Journal of Cardiovascular Pharmacology Anesthetic MechanismPharmacotherapyExperimental PharmacologyNeuromuscular BlockadeMolecular Pharmacology	2004	14
Effects of Renin Inhibitor A-72517 on Hemodynamics and Cardiac Function in Sodium-Depleted Dogs Jerry L. Wessale, Hollis D. Kleinert, Samuel V. Calzadilla, American Journal of Hypertension	1993	11

Page 1